DocuSign (DOCU) is down about 3% in Thursday trading, with the tape reflecting continued pressure from a more cautious analyst backdrop and renewed attention on insider-selling activity disclosed in recent SEC filings. The stock has been trading near recent lows, leaving it more sensitive to incremental negative catalysts and positioning shifts. (intellectia.ai)

A key overhang is a recent reset in Street expectations. Bank of America reinstated coverage with an Underperform rating and a $52 price target, framing the call around growth and durability concerns—an outlook that can act as a near-term drag as investors reprice the risk/reward and wait for clearer signs of re-acceleration. (intellectia.ai)

Sentiment is also being weighed down by disclosed insider sales: the chief legal officer reported selling 12,000 shares on April 1, 2026 (about $562,000), and filings also flagged CEO sales executed under a 10b5-1 plan. Even when pre-arranged, clustered selling can amplify caution when a stock is already under pressure. (investing.com)

Traders are now focused on whether additional research notes follow with further target reductions, and whether options positioning shows heavier downside hedging into upcoming catalysts. The next upside catalyst likely requires evidence that product/platform initiatives translate into steadier growth and improved retention/expansion metrics, rather than just margin and buyback support. (barchart.com)